Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
developing an innovative microfluidic platform for human iPS cell-based neurodegenerative disease modeling. The project focuses on differentiating iPS cells to neurons, glia and other cell types involved in
-
regulatory compliance into the design of microfluidic assays. Model and optimise the separation of blood cells and blood flow properties within microfluidic devices. Model and optimise red blood cell and
-
expression using microfluidic analysis. Applications – Applicants should send the following documents in PDF for luiz.stasi@unesp.br (deadline December 12, 2025): 1. A cover letter (maximum two pages A4
-
duration of 3 years, starting in Summer 2026. Objective of the project: Finnadvance is an organ-on-chip company that has developed the AKITA microfluidic platform. It elicits the generation of biological
-
PhD or a PhD near completion in cell biology, bioengineering, bioscience, molecular biology or a related field. Candidates should have extensive experience of working with microfluidic chips, mammalian
-
integrating them with microfluidics as a standalone device. This is a great opportunity to learn new skills, contribute to assay development, and intellectually contribute to projects within a collaborative
-
of manufacturing. We have identified an opportunity to combine continuous microfluidic (µF) process models, process analytical technology (PAT) and machine learning (ML) to achieve a paradigm shift in bioprocess
-
also be subjected to droplet microfluidics, one of the most promising high-throughput methods for effectively processing the MIP-probe-positive individual cells for RNAseq analysis by using our standard
-
of manufacturing. We have identified an opportunity to combine continuous microfluidic (µF) process models, process analytical techn ology (PAT) and machine learning (ML) to achieve a paradigm shift in bioprocess
-
microfluidic chip to simulate inter-organ crosstalk and dynamic hormone regulation. A panel of environmentally relevant chemicals and mixtures will be applied to evaluate dose–response effects and mechanisms